-+ 0.00%
-+ 0.00%
-+ 0.00%

ORIC PHARMACEUTICALS, INC. : LEERINK PARTNERS INITIATES COVERAGE WITH OUTPERFORM RATING; TARGET PRICE $26

Reuters·10/05/2026 10:04:12

Please log in to view news